Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
This study is ongoing, but not recruiting participants.
Study NCT00462215   Information provided by Baxter Healthcare Corporation
First Received: April 17, 2007   Last Updated: July 21, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Influenza
Additional conditions recognized in this trial
Influenza, Human
More general conditions related to this trial
Orthomyxoviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Virus Diseases
Sponsors listed in this trial
Baxter Healthcare Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services